Ferenc Gallyas Selected Research

Ferenc Gallyas Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 03/2002
10	Inflammation (Inflammations) 01/2021 - 07/2004
7	Necrosis 01/2017 - 05/2002
6	Hypertension (High Blood Pressure) 01/2021 - 01/2013
6	Ischemia 01/2013 - 04/2003
5	Multiple Sclerosis 01/2020 - 03/2010
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
4	Hypertrophy 01/2021 - 07/2006
4	Heart Failure 01/2021 - 07/2006
4	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 03/2010
3	Triple Negative Breast Neoplasms 01/2022 - 02/2021
3	Disease Progression 01/2021 - 01/2017
3	Shock 01/2021 - 05/2002
3	Septic Shock (Toxic Shock Syndrome) 02/2009 - 04/2003
3	Retinal Degeneration 09/2007 - 07/2006
2	Breast Neoplasms (Breast Cancer) 08/2021 - 02/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 01/2009
2	Vascular Remodeling 01/2017 - 07/2014
2	Cardiomegaly (Heart Hypertrophy) 06/2009 - 07/2006
2	Fibrosis (Cirrhosis) 06/2009 - 07/2006
2	Infarction (Infarctions) 09/2006 - 02/2006
1	Crohn Disease (Crohn's Disease) 01/2021
1	Colitis 01/2021
1	Sepsis (Septicemia) 01/2021
1	Endotoxemia 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 10/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Retinal Diseases 01/2019
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2018

Drug/Important Bio-Agent (IBA)

15	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2021 - 04/2003
11	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2021 - 05/2002
8	Pharmaceutical PreparationsIBA 08/2021 - 07/2006
8	Phosphotransferases (Kinase)IBA 02/2020 - 07/2004
7	Cytostatic AgentsIBA 08/2021 - 01/2009
6	LipopolysaccharidesIBA 01/2021 - 05/2002
6	BGP 15IBA 01/2021 - 03/2002
6	EnzymesIBA 04/2020 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2006
5	desethylamiodaroneIBA 01/2022 - 11/2003
5	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022 - 04/2003
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 09/2006
4	CuprizoneIBA 01/2020 - 03/2010
4	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2019 - 05/2002
4	2- ((2- piperidin- 1- ylethyl)thio)quinazolin- 4(3H)- oneIBA 01/2017 - 07/2006
3	olaparibIBA 02/2021 - 01/2019
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2021 - 07/2004
3	Adenosine Triphosphate (ATP)IBA 06/2012 - 10/2005
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2012 - 04/2003
3	PolyphenolsIBA 01/2011 - 02/2009
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 11/2010 - 07/2006
3	Sodium Glutamate (Accent)IBA 09/2007 - 07/2006
3	EndotoxinsIBA 07/2004 - 05/2002
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 02/2021 - 02/2006
2	CollagenIBA 01/2021 - 07/2006
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021 - 01/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 05/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2002
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2014
2	Small Heat-Shock ProteinsIBA 01/2015 - 12/2007
2	Transcription Factors (Transcription Factor)IBA 07/2014 - 07/2004
2	NF-kappa B (NF-kB)IBA 07/2014 - 07/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 01/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014 - 07/2006
2	CytokinesIBA 01/2014 - 11/2010
2	ChemokinesIBA 01/2014 - 11/2010
2	Phosphates (Orthophosphate)IBA 06/2012 - 04/2003
2	Mitogen-Activated Protein KinasesIBA 05/2012 - 07/2006
2	ferulaldehydeIBA 01/2011 - 02/2009
2	Apoptosis Inducing FactorIBA 03/2010 - 11/2003
2	Protein Kinase CIBA 06/2009 - 07/2006
2	Adenosine (Adenocard)FDA LinkGeneric 07/2006 - 05/2002
2	Glycogen Synthase Kinase 3 betaIBA 07/2006 - 02/2006
2	Carisoprodol (Soma)FDA LinkGeneric 06/2006 - 05/2004
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2006 - 07/2004
1	Anti-Arrhythmia AgentsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	nitroxylIBA 08/2021
1	pyrrolineIBA 08/2021
1	mito-carboxy proxylIBA 08/2021
1	Platinum Compounds (Compounds, Platinum)IBA 02/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	Hormones (Hormone)IBA 02/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Sulfonic AcidsIBA 01/2021
1	Cyclophilins (Cyclophilin)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	sym-trinitrobenzeneIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Therapeutic UsesIBA 04/2020
1	Neuroprotective AgentsIBA 10/2019
1	vinpocetineIBA 10/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019

Therapy/Procedure

13	Therapeutics 08/2021 - 01/2009